Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Sponsor: Kat Cammack (Republican-FL)September 9, 2025

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Referred to the House Committee on Energy and Commerce.

House would back standard testing for a condition linked to miscarriages and pregnancy complications.

The House of Representatives would express its support for routinely testing pregnant people for antiphospholipid syndrome (APS). This condition can increase the risk of miscarriages, stillbirths, and other pregnancy issues. The resolution also asks medical groups to update their guidelines to include this testing as a standard part of prenatal care.

What Would Change

Today, medical groups only recommend testing for antiphospholipid syndrome (APS) after a woman has had certain pregnancy losses. If this resolution passes and medical groups update their advice, testing for APS could become a standard part of prenatal screening for all pregnant individuals, potentially preventing some miscarriages and stillbirths.

Key Provisions

Supports testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening.
Calls upon professional medical associations and guideline-setting bodies to update their recommendations to include standard APS testing.

View on Congress.gov

HRES 685 · 119th Congress · September 9, 2025 · AI Summary by gemini-2.5-flash · 9/10

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

What Would Change

Key Provisions

Lobbying Activity